Cell-based regenerative medicine for heart disease

Fundamentals of Tissue Engineering and Regenerative Medicine

Volumn , Issue , 2009, Pages 441-452

  Stamm, Christof ^a   Lüders, Cora ^a   Nasseri, Boris ^a   Hetzer, Roland ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870785107     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-77755-7_33     Document Type: Chapter

References (72)

1. Rota M, Hosoda T, De Angelis A, et al. The young mouse heart is composed of myocytes heterogeneous in age and function. Circ Res; 2007:387-99
2. Bittmann I, Hentrich M, Bise K, et al. Endothelial cells but not epithelial cells or cardiomyocytes are partially replaced by donor cells after allogeneic bone marrow and stem cell transplantation. J Hematother Stem Cell Res; 2003;12:359-66
3. Deb A, Wang S, Skelding KA, et al. Bone marrow-derived cardiomyocytes are present in adult human heart: a study of gender-mismatched bone marrow transplantation patients. Circulation 2003;107:1247-9
4. Jiang S, Walker L, Afentoulis M, et al. Transplanted human bone marrow contributes to vascular endothelium. Proc Natl Acad Sci U S A 2004;101:16891-6
5. Minami E, Lafamme MA, Safftz JE, et al. Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart. Circulation 2005;112:2951-8
6. Lafamme MA, Myerson D, Safftz JE, et al. Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res 2002;90:634-40
7. Torella D, Ellison GM, Karakikes I, et al. Resident cardiac stem cells. Cell Mol Life Sci 2007;64:661-73
8. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003;114:763-76
9. Oh H, Bradfute SB, Gallardo TD, et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 2003;100:12313-8
10. Oyama T, Nagai T, Wada H, et al. Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. J Cell Biol 2007;176:329-41
11. Bearzi C, Rota M, Hosoda T, et al. Human cardiac stem cells. Proc Natl Acad Sci U S A 2007;104:14068-73
12. Messina E, De Angelis L, Frati G, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004;95:911-21
13. Smith RR, Barile L, Cho HC, et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007;115:896-908
14. Laugwitz KL, Moretti A, Lam J, et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005;433:647-53
15. Chiu RC, Zibaitis A, Kao RL. Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg 1995;60:12-8
16. Marelli D, Desrosiers C, el-Alfy M, et al. Cell transplantation for myocardial repair: an experimental approach. Cell Transplant 1992;1:383-90
17. Leor J, Patterson M, Quinones MJ, et al. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium? Circulation 1996;94:II332-6
18. Taylor DA, Atkins BZ, Hungspreugs P, et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998;4:929-33
19. Menasche P, Hagege AA, Scorsin M, et al. Myoblast transplantation for heart failure. Lancet 2001;357:279-80
20. Rubart M, Soonpaa MH, Nakajima H, et al. Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation. J Clin Invest 2004;114:775-83
21. Dib N, Michler RE, Pagani FD, et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 2005;112:1748-55
22. Behfar A, Zingman LV, Hodgson DM, et al. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J 2002;16:1558-66
23. Dai W, Field LJ, Rubart M, et al. Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J Mol Cell Cardiol 2007;43:504-16
24. Menard C, Hagege AA, Agbulut O, et al. Transplantation of cardiac-committed mouse embryonic stem cells to in-farcted sheep myocardium: a preclinical study. Lancet 2005;366:1005-12
25. Behfar A, Perez-Terzic C, Faustino RS, et al. Cardiopoi-etic programming of embryonic stem cells for tumor-free heart repair. J Exp Med 2007;204:405-20
26. Byrne JA, Pedersen DA, Clepper LL, et al. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature 2007;450:497-502
27. Guan K, Wagner S, Unsold B, et al. Generation of functional cardiomyocytes from adult mouse spermatogonial stem cells. Circ Res 2007;100:1615-25
28. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluri-potent stem cell lines derived from human somatic cells. Science 318:1917-20
29. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fbroblasts by defned factors. Cell 2007;131:861-72
30. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fbroblast cultures by defned factors. Cell 2006;126:663-76
31. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascu-larization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apopto-sis, reduces remodeling and improves cardiac function. Nat Med 2001;7:430-6
32. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5
33. Murry CE, Soonpaa MH, Reinecke H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myo-cytes in myocardial infarcts. Nature 2004;428:664-8
34. Rota M, Kajstura J, Hosoda T, et al. Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci U S A 2007;104:17783-8
35. Friedenstein AJ, Petrakova K V, Kurolesova AI, et al. Heterotopic of bone marrow. analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968;6:230-47
36. Prockop DJ. Marrow stromal cells as stem cells for non-hematopoietic tissues. Science 1997;276:71-4
37. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991;9:641-50
38. Le Blanc K, Ringden O. Immunomodulation by mes-enchymal stem cells and clinical experience. J Int Med 2007;262:509-25
39. Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999;103:697-705
40. Hakuno D, Fukuda K, Makino S, et al. Bone marrow-derived regenerated cardiomyocytes (CMG cells) express functional adrenergic and muscarinic receptors. Circulation 2002;105:380-6
41. Hattan N, Kawaguchi H, Ando K, et al. Purifed cardio-myocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice. Cardiovasc Res 2005;65:334-44
42. Toma C, Pittenger MF, Cahill KS, et al. Human mes-enchymal stem cells differentiate to a cardiomyo-cyte phenotype in the adult murine heart. Circulation 2002;105:93-8
43. Wollert KC, Meyer GP, Lotz J, et al. Intracoronary au-tologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364:141-8
44. Assmus B, Fischer-Rasokat U, Honold J, et al. Transcor-onary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry. Circ Res 2007;100:1234-41
45. Assmus B, Honold J, Schachinger V, et al. Transcoro-nary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006;355:1222-32
46. Janssens S, Dubois C, Bogaert J, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006;367:113-21
47. Lunde K, Solheim S, Aakhus S, et al. Intracoronary injection of mononuclear bone marrow cells in acute myo-cardial infarction. N Engl J Med 2006;355:1199-209
48. Schachinger V, Erbs S, Elsasser A, et al. Intracoronary bone marrow-derived progenitor cells in acute myocar-dial infarction. N Engl J Med 2006;355:1210-21
49. Lunde K, Solheim S, Aakhus S, et al. Exercise capacity and quality of life after intracoronary injection of autolo-gous mononuclear bone marrow cells in acute myocardial infarction: results from the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) randomized controlled trial. Am Heart J 2007;154:710 e1-8
50. Perin EC, Dohmann HF, Borojevic R, et al. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 2004;110:II213-8
51. Brehm M, Strauer BE. Stem cell therapy in postinfarction chronic coronary heart disease. Nat Clin Pract Car-diovasc Med 2006;3:S101-4
52. Galinanes M, Loubani M, Davies J, Chin D, Pasi J, Bell PR. Autotransplantation of unmanipulated bone marrow into scarred myocardium is safe and enhances cardiac function in humans. Cell Transpl 2004;13:7-13
53. Erbs S, Linke A, Adams V, et al. Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: frst randomized and placebo-controlled study. Circ Res 2005;97:756-62
54. Patel AN, Geffner L, Vina RF, et al. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. J Thorac Cardiovasc Surg 2005;130:1631-8
55. Stamm C, Kleine HD, Westphal B, et al. CABG and bone marrow stem cell transplantation after myocardial infarction. Thorac Cardiovasc Surg 2004;52:152-8
56. Stamm C, Westphal B, Kleine HD, et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003;361:45-6
57. Stamm C, Kleine HD, Choi YH, et al. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and effcacy studies. J Thorac Cardiovasc Surg 2007;133:717-25
58. Pompilio G, Cannata A, Peccatori F, et al. Autologous peripheral blood stem cell transplantation for myocardial regeneration: a novel strategy for cell collection and surgical injection. Ann Thorac Surg 2004;78:1808-12
59. Losordo DW, Schatz RA, White CJ, et al. Intramyocar-dial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation 2007;115:3165-72
60. Amado LC, Saliaris AP, Schuleri KH, et al. Cardiac repair with intramyocardial injection of allogeneic mesen-chymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 2005;102:11474-9
61. Grinnemo KH, Mansson A, Dellgren G, et al. Xenoreac-tivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. J Thorac Cardiovasc Surg 2004;127:1293-300
62. Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 2001;98:10344-9
63. Ince H, Stamm C, Nienaber CA. Cell-based therapies after myocardial injury. Curr Treat Options Cardiovasc Med 2006;8:484-95
64. Messas E, Bel A, Morichetti MC, et al. Autologous myo-blast transplantation for chronic ischemic mitral regurgitation. J Am Coll Cardiol 2006;47:2086-93
65. Klein HM, Ghodsizad A, Borowski A, et al. Autologous bone marrow-derived stem cell therapy in combination with TMLR. A novel therapeutic option for endstage coronary heart disease: report on 2 cases. Heart Surg Forum 2004;7:E416-9
66. Ya u TM, Kim C, Ng D, et al. Increasing transplanted cell survival with cell-based angiogenic gene therapy. Ann Thorac Surg 2005; 80: 1779-86
67. Zhang M, Methot D, Poppa V, et al. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 2001;33:907-21
68. Li W, Ma N, Ong LL, et al. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 2007;25:2118-27
69. Mangi AA, Noiseux N, Kong D, et al. Mesenchy-mal stem cells modifed with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003;9:1195-201
70. Sasaki K, Heeschen C, Aicher A, et al. Ex vivo pretreat-ment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy. Proc Natl Acad Sci U S A 2006;103:14537-41
71. Spyridopoulos I, Haendeler J, Urbich C, et al. Statins enhance migratory capacity by upregulation of the telom-ere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation 2004;110:3136-42
72. Maurel A, Azarnoush K, Sabbah L, et al. Can cold or heat shock improve skeletal myoblast engraftment in in-farcted myocardium? Transplantation 2005;80:660-5